DCP, Sequoia China lead Series B round for medical devices firm Valgen

DCP, Sequoia China lead Series B round for medical devices firm Valgen

Source: Valgen Medtech

06 May, 2021

DCP heart valve mitral and tricuspid valves Sequoia Capital China Valgen Medtech

Printed by Unregistered user on Sun, 07 Dec 2025 21:01:23 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Blank cheque firm Summit Healthcare files for $200m IPO, eyes target with China link

Venture Capital

Qiming US in the market to raise $300m for third healthcare fund

Read more from Greater China

Alibaba to retire Ele.me brand amid instant-retail push

HongShan aims for $2.9b sale of Golden Goose to Permira by Christmas: report